Almost half of 20 to 29 years old have now had at least one dose of the vaccine

The Ministry of Health of the Canary Islands has informed that the SCS have now administered almost 2.6 million (2,598,451) doses of the vaccines against Covid-19 of the 2,750,280 received, which represents 94.48%. In addition, up until yesterday the immunization of 1,230,325 people who have already been fully vaccinated had been achieved, which represents 62.7% of the target population over 12 years of age in the Canary Islands.

There are now 1,508,462 people who have received at least one dose of the vaccine in the Archipelago, which is 76.93% of the target population of 1,960,774 people over 12. Taking the population over 16 years of age as reference, 80.62% have been vaccinated.

As you can see below, Groups 1-7 are now complete and Group 9, those aged 50-59, is almost complete, so now the focus is on inoculating the younger generation less than 50 years old as soon as possible. Group 8, which is people aged 60 to 65, is finally catching up after it was delayed and they have a longer 12 week wait in between jabs for the AstraZeneca vaccine.

Group coverage so far:
In the latest revision of the National Vaccination Strategy, the following vaccination and prioritization groups are established:

Stage I:

Group 1: COMPLETE. Residents of nursing homes and social health centres

Group 2: COMPLETE. Front-line health and social health personnel:

Group 3: COMPLETE. Non-front-line health and social health personnel:

Group 4: COMPLETE. Large household dependents.

Stage II:

Group 5: COMPLETE. People aged over 65.
Group 5A: People aged 80 and over
Group 5B: People from 70 to 79 years old
Group 5C: People from 66 to 69 years old

Group 6: COMPLETE. Groups with an essential function for society: police, army, emergency services, teachers.

Group 7: COMPLETE. People under 60 years of age with severe Covid-19 high-risk conditions, ie health complications.

Group 8: 81.10% one dose and 55.50% two doses. People aged 60-65 years old.

Group 9: 100% one dose and 93.32% two doses. People aged 50-59 years old.

Group 10: 68.96% with full schedule. People aged 40-49 years old.

Stage III:

Group 11: 56.56% with one dose and 38.59% with two doses. People between 30 and 39 years old.

Group 12: 49.79% with one dose. People between 20 and 29 years old.

Group 13: 42.52% with one dose. People between 12 and 19 years old.